Telerehabilitation in Patients With Pulmonary Hypertension

Sponsor

Marmara University (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT04683822

Collaborator

(none)

Enrollment

Arms

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Patients with pulmonary hypertension will be randomized into two groups. One group will receive telerehabilitation sessions including upper and lower extremity strengthening exercises and breathing exercises. The other will me monitored routinely. Patients will be assessed by 6 minute walk test, emphasis-10 questionnaire for quality of life and muscle strength with hand-held dynamometer.

Condition or Disease	Intervention/Treatment	Phase
Pulmonary Hypertension	Other: Telerehabilitation	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

30 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Outcomes Assessor)

Primary Purpose:

Supportive Care

Official Title:

Investigation of the Effectiveness of a Home Exercise Program Combined With Telerehabilitation in Pulmonary Hypertension Patients

Anticipated Study Start Date :

Jan 1, 2021

Anticipated Primary Completion Date :

May 1, 2021

Anticipated Study Completion Date :

Jun 1, 2021

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Exercise group Patients who receive telerehabilitaton	Other: Telerehabilitation Patients will attend telerehabilitation sessions
No Intervention: Control Patients with routine care

Arm

Intervention/Treatment

Experimental: Exercise group

Patients who receive telerehabilitaton

Other: Telerehabilitation

Patients will attend telerehabilitation sessions

No Intervention: Control

Patients with routine care

Outcome Measures

Primary Outcome Measures

Muscle strength [3 months]
Muscle strength measured with hand held dynamometer

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 65 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients with pulmonary hypertension

Exclusion Criteria:

Patients with severe exercise intolerance
Patients with musculoskeletal problems that hinder exercise
Patients who refuse to join the study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Marmara University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Marmara University

ClinicalTrials.gov Identifier:

NCT04683822

Other Study ID Numbers:

1443

First Posted:

Dec 24, 2020

Last Update Posted:

Dec 24, 2020

Last Verified:

Dec 1, 2020

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Hypertension, Pulmonary

Hypertension

Study Results

No Results Posted as of Dec 24, 2020